2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Neoplasms
7
Venous Thromboembolism
3
Venous Thrombosis
2
Thrombosis
2
Thromboembolism
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Sarcoma, Alveolar Soft Part
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Prostate Cancer Patients
1
Pneumonia
1
Pharmacokinetics of MDV3100
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Interventions
emicizumab
4
Factor VIII
2
ziprasidone
1
recombinant FVIIa
1
anti-inhibitor coagulant complex
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Deamino Arginine Vasopressin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemophilia A
×
Warfarin
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled